Current Report Filing (8-k)
May 07 2019 - 6:53AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 7, 2019
MODERNA, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-38753
|
|
81-3467528
|
(State or other jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification Number)
|
|
|
|
200 Technology Square
Cambridge, MA
|
|
02139
|
(Address of registrants principal executive office)
|
|
(Zip code)
|
(617)
714-6500
(Registrants telephone number, including area code)
N/A
(Former name or
former address, if changed since last report)
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 203.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17
CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule
12b-2
of the Securities Exchange Act of 1934.
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to
Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading symbol(s)
|
|
Name of each exchange
on which registered
|
Common stock, par value $0.0001
per share
|
|
MRNA
|
|
The NASDAQ Stock Market LLC
|
Item 7.01 Regulation FD Disclosure
As previously announced, Moderna, Inc. (the Company) will give a live webcast today, May 7, 2019, in conjunction with its 2019 Science Day and
host a tour of its Norwood manufacturing facility in the afternoon. The Science Day webcast and Norwood manufacturing facility tour will include slide presentations, excerpts of which are attached as Exhibits 99.1 and 99.2,
respectively, to this Current Report on Form
8-K
and are incorporated by reference in this Item 7.01.
The Science
Day webcast will be available on the Companys website for at least 30 days following the event. The information contained on the Companys website is not part of this Form
8-K
and is not
incorporated by reference into this Form
8-K.
The information in this Item 7.01 to this Current Report on
Form 8-K,
and in Exhibits 99.1 and 99.2 furnished herewith, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange
Act), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by
specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
Date: May 7, 2019
|
|
|
|
MODERNA, INC.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Lori Henderson
|
|
|
|
|
|
|
Lori Henderson
|
|
|
|
|
|
|
General Counsel and Corporate Secretary
|
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Apr 2023 to Apr 2024